1. Home
  2. FENC vs HPI Comparison

FENC vs HPI Comparison

Compare FENC & HPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fennec Pharmaceuticals Inc.

FENC

Fennec Pharmaceuticals Inc.

SELL

Current Price

$12.49

Market Cap

366.8M

Sector

Health Care

ML Signal

SELL

HPI

John Hancock Preferred Income Fund of Beneficial Interest

SELL

Current Price

$12.55

Market Cap

360.0M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
FENC
HPI
Founded
1996
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
366.8M
360.0M
IPO Year
2010
2002

Fundamental Metrics

Financial Performance
Metric
FENC
HPI
Price
$12.49
$12.55
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $17.40
N/A
AVG Volume (30 Days)
★ 180.6K
115.6K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.19
N/A
Revenue
★ $44,642,000.00
N/A
Revenue This Year
$67.26
N/A
Revenue Next Year
$42.94
N/A
P/E Ratio
$67.21
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.65
$12.42
52 Week High
$13.25
$17.04

Technical Indicators

Market Signals
Indicator
FENC
HPI
Relative Strength Index (RSI) 65.46 29.79
Support Level $9.58 N/A
Resistance Level $12.79 $16.39
Average True Range (ATR) 0.86 0.24
MACD 0.19 -0.02
Stochastic Oscillator 81.90 12.29

Price Performance

Historical Comparison
FENC
HPI

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

About HPI John Hancock Preferred Income Fund of Beneficial Interest

John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.

Share on Social Networks: